Back to Search
TYLER WEBSTER, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1326466087IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
288324(NY)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 2014
Research & Publications (20)
Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. II. Mechanisms of osteoblast adhesion.
PMID 11745568·J Biomed Mater Res·2002
7-preclinical
Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin.
PMID 11429149·Tissue Eng·2001
4-observational
Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics.
PMID 10880091·J Biomed Mater Res·2000
7-preclinical
Method for mapping population-based case-control studies: an application using generalized additive models.
PMID 16764727·Int J Health Geogr·2006
8-other
Commentary: does the spectre of ecologic bias haunt epidemiology?
PMID 11914313·Int J Epidemiol·2002
8-other
Enhanced osteoclast-like cell functions on nanophase ceramics.
PMID 11336305·Biomaterials·2001
7-preclinical
Enhanced functions of osteoblasts on nanophase ceramics.
PMID 10905463·Biomaterials·2000
7-preclinical
An understanding of enhanced osteoblast adhesion on various nanostructured polymeric and metallic materials prepared by ionic plasma deposition.
PMID 19322818·J Biomed Mater Res A·2010
8-other
Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method.
PMID 19582847·J Biomed Mater Res B Appl Biomater·2009
8-other
Increased endothelial cell adhesion and elongation on micron-patterned nano-rough poly(dimethylsiloxane) films.
PMID 19581692·Nanotechnology·2009
7-preclinical
Biologically inspired rosette nanotubes and nanocrystalline hydroxyapatite hydrogel nanocomposites as improved bone substitutes.
PMID 19420581·Nanotechnology·2009
8-other
Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay.
PMID 19592503·Mutagenesis·2009
8-other
Generalized concentration addition: a method for examining mixtures containing partial agonists.
PMID 19345693·J Theor Biol·2009
8-other
The role of polymer nanosurface roughness and submicron pores in improving bladder urothelial cell density and inhibiting calcium oxalate stone formation.
PMID 19417440·Nanotechnology·2009
8-other
A new spin on research translation: the Boston Consensus Conference on Human Biomonitoring.
PMID 19440485·Environ Health Perspect·2009
8-other
Identifying transfer mechanisms and sources of decabromodiphenyl ether (BDE 209) in indoor environments using environmental forensic microscopy.
PMID 19534115·Environ Sci Technol·2009
8-other
Nanotechnology controlled drug delivery for treating bone diseases.
PMID 19637973·Expert Opin Drug Deliv·2009
6-review
Enhanced endothelial cell functions on rosette nanotube-coated titanium vascular stents.
PMID 19516887·Int J Nanomedicine·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE
NEW YORK, NY 10016 - Phone
- (212) 263-6554
Quick Facts
- NPI
- 1326466087
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile